Climb Bio, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Share-based Compensation 0.71M3.74M6.99M12.81M5.56M
Gains from Investment Securities 0.92M0.31M6.35M
Asset Writedowns and Impairment 0.18M
Cash from Operations -14.10M-36.07M-37.37M-20.60M-15.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.37M0.18M2.33M0.76M
Change in Working Capital
Change in Account Payables -0.17M0.32M-0.65M-0.69M-0.96M
Change in Accured Expenses 0.96M3.20M0.42M-2.61M1.45M
Investing Activities
Capital Expenditures 4.64M
Change in Acquisitions & Divestments 122.40M127.43M20.75M
Cash from Investing Activities 8.08M-114.97M34.44M68.98M-121.09M
Financing Activities
Change in Capital Stock
Shares Issued 0.15M0.84M119.75M
Preferred Shares Issued 4.92M93.94M
Misc.
Cash from Financing Activities 4.92M177.23M0.84M130.73M
Exchange Rate Effect 0.36M0.24M-0.41M0.30M0.04M
Change in Cash -0.74M26.43M-3.34M49.53M-5.88M
Free Cash Flow -14.10M-36.07M-37.37M-20.60M-20.21M
Net Cash Flow -1.09M26.19M-2.93M49.22M-5.92M